DETROIT - A Wayne State University School of Medicine physician-researcher has developed a personalized therapy to treat a wide range of cancers based on a naturally occurring human enzyme that has been genetically modified to fool cancer cells into killing themselves. The unique concept, patented by Wayne State University, was successfully demonstrated on melanoma cells
ALLEGAN - Perrigo Tuesday announced that the Detroit office of the Food and Drug Administration has arrived to reinspect its facilities for equipment failures last spring that included inadequate handling of metal shavings in a batch of bottles to be filled with Ibuprofen tablets. In the case of the metal shavings, Perrigo caught the problem
ANN ARBOR - The Michigan Biosciences Legislative Caucus kicks off 2011 with new leadership and scheduled quarterly meetings, MichBio, the state life sciences trade association reported. The body will be led by Sens. Rebekah Warren (D-Ann Arbor, a founding co-chair) and Tonya Schuitmaker (R-Kalamazoo), and Reps. Gail Haines (R-Waterford) and Roy Schmidt (Grand Rapids) in
TROY - gloStream, an electronic medical record and practice management software with Microsoft Office built in ? announced the release of gloEMR 6.0., the sixth major upgrade to the gloEMR product line. Like its predecessor versions, gloEMR 6.0 leverages a variety of Microsoft technology such as the .NET platform, SQL Server and Microsoft Office so
LANSING ? Neogen has named Steven J. Quinlan as the Company's chief financial officer to replace the retiring Richard Current. Current will immediately relinquish his responsibilities as CFO, but will remain with Neogen through the end of the fiscal year, May 31. Quinlan joins Neogen following 19 years at Detrex Corporation, the last eight as
PLYMOUTH - Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, Thursday announced that it has initiated a Phase 2 clinical study for small molecule compound that has the potential to regulate cholesterol, triglycerides and other cardio risk factors. ETC-1002 is a novel small molecule
YPSILANTI - Integrated Sensing Systems has received two federal grants to aid in the support of its wireless implantable pressure sensors for the chronic treatment of congestive heart failure, as well as its drug infusion flow sensing technology for much safer drug administration. ISSYS applied for these grants earlier in the year under the Qualifying
KALAMAZOO - ProNAi Therapeutics is a drug development and discovery company founded by pharmaceutical development professionals who chose to stay in Michigan when Pfizer shut down operations in Kalamazoo. A biopharmaceutical company located at Kalamazoo's Southwest Michigan Innovation Center, ProNAi is pioneering a new class of therapies for treating cancer; therapies that use naturally occurring
ANN ARBOR - NanoBio Corporation announced Tuesday that it has received a $6 million grant from the Bill & Melinda Gates Foundation to support the development of a safe and effective intranasal vaccine for Respiratory Syncytial Virus, a highly contagious viral disease and is one of the most common causes of bronchiolitis and pneumonia. RSA
DETROIT - Wayne State University physiology assistant professor Patrick J. Mueller has been awarded a $1 million grant from the National Institutes of Health to study how alterations in the brain caused by inactivity may contribute to an individual's risk of cardiovascular disease. Physical inactivity is considered a major risk factor of cardiovascular disease, the